+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 75Years
All Genders
ID06019702

Study of Personalized mRNA Vaccine iNeo-Vac-R01 for Advanced Digestive System Cancers Evaluating Safety, Feasibility, and Effectiveness in Adults

Led by Sir Run Run Shaw Hospital · Updated on 2023-09-11

20

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, feasibility, and effectiveness of a personalized mRNA vaccine called iNeo-Vac-R01 in people with advanced digestive system cancers. This phase 1 clinical study focuses on patients whose cancer has progressed after standard treatments or who cannot tolerate or choose not to receive standard therapies. The study includes a dose escalation phase followed by a dose expansion phase to find the best dose for further testing. Participants will receive iNeo-Vac-R01 through a hypodermic injection under the skin on the first day of each 21-day cycle, for up to 9 cycles. During the dose escalation phase, groups of 3 to 6 subjects will receive increasing doses of 50, 100, and 150 micrograms to determine the optimal dose. Then, this chosen dose will be used in the dose expansion phase to further evaluate the vaccine. Throughout the study, researchers will monitor participants closely for adverse events, dose-limiting toxicities, and treatment feasibility. They will also assess survival rates, tumor response, disease control, immune responses, and other health measures over several years after treatment begins. Participants will undergo tumor tissue collection or provide existing genetic data, blood tests, heart function tests, and clinical evaluations to support these assessments and ensure safety and adherence to the protocol.

CONDITIONS

Brief Title

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms

Research Team

X

Xiujun Cai, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here